Endo Health (ENDP) pulls its 2013 guidance, saying it no longer expects to hit its EPS target of between $5.20 - $5.40 on revenues of $3.0B - $3.2B. The company says it will provide updated 2013 guidance in early January. Street consensus estimates are for an EPS of $5.21 on revenue of $3.08B. Additionally, the company says that CEO David P. Holveck, will retire in 2013. Shares -7.3% AH.